University Hospital in Pilsen, Department of Nuclear Medicine - Immunoanalytic Laboratory, Czech Republic.
Biomark Med. 2013 Jun;7(3):407-14. doi: 10.2217/bmm.13.39.
This is the second article dedicated to The Annual 40th Congress of the International Society of Oncology and Biomarkers, which took place in Jerusalem, Israel. This second part of this article will be dedicated to the special presentations from individual sessions. Sessions were organised according to the cancer type or etiopathogenesis, while some sessions were dedicated to the relationship between diagnostics and therapy choice.
这是第二篇专门介绍在以色列耶路撒冷举行的第 40 届国际肿瘤学和生物标志物学会年度大会的文章。本文的第二部分将专门介绍各个专场的特别报告。专场是根据癌症类型或病因学组织的，而有些专场则专门讨论了诊断与治疗选择之间的关系。
